In vivo pharmaco-proteomic analysis of h
โ
Swati S. Ghatpande; Pankaj K. Choudhary; Charles T. Quinn; Steven R. Goodman
๐
Article
๐
2010
๐
Elsevier
๐
English
โ 519 KB
Hydroxyurea (HU) is an effective drug for the treatment of sickle cell disease (SCD). The main clinical benefit of HU is thought to derive from its capacity to increase fetal hemoglobin (HbF) production. However, other effects leading to clinical benefit, such as improved blood rheology, have been s